Posts Tagged ‘Canadian drug importation’
Colorado’s Canadian drug importation plan won’t be safe and also won’t save money
Colorado submitted its application to the FDA to import medicine from Canada on December 5. Like other Canadian importation plans, this one isn’t safe and it’s unlikely to save money.
[...]Why has Florida paid 27 million dollars for an empty warehouse?
When Governor Ron DeSantis signed HB19 into law in June 2019, he said that Florida was leading “the way toward affordable prescription drugs,” but over the past three years not a single person has received even one pill imported from Canada, and the state has spent millions.
[...]Drug Importation Is Not The Solution Americans Need
While working to find a way to provide relief to patients at the pharmacy counter, American politicians again look to the idea of drug importation as a possible solution. Looking at all the evidence, the Partnership for Safe Medicines believes such plans will not only make no difference in reducing patient out-of-pocket costs, but will…
[...]Connecticut Bioscience Growth Council ED explains why drug importation is “unworkable.”
In this February 24, 2022 editorial published on the Connecticut Business & Industry Association’s website, Paul Pescatello reviews the practical reasons that mean that importing drugs from Canada will not lower prescription drug prices. Pescatello is the executive director of CBIA’s Bioscience Growth Council and chair of We Work for Health Connecticut.
[...]“Reducing costs requires more than all of this non–value-added activity,” Expert Says
In this October 23, 2020 editorial, which was published in the The American Journal of Managed Care, Michael Abrams explains why drug importation will not save patients money. Abrams is the co-founder and managing partner of Numerof & Associates.
[...]Counterfeit Medicine: Crime and Policy, October 20, 2020
A summary briefing of 2020’s major cases, worrying trends and a deep dive into drug supply chain policy issues.
[...]“…barriers will delay or prevent drug importation,” say regulatory experts
In this analysis, which was published in Lexology on October 13, 2020, three global regulatory experts examine barriers to drug importation.
[...]Counterfeit Medicine News for the Week of October 5, 2020
In PSM’s round-up this week: Policy truths about drug importation, prosecutions for fake COVID-19 treatments and financial fraud, and another week in counterfeit pills.
[...]Counterfeit Medicine News for the Week of September 28, 2020
In PSM’s round-up this week: A new report about the counterfeit medicine trade, fake COVID-19 vaccines in India, the week in counterfeit pills.
[...]Counterfeit Medicine News for the Week of September 21, 2020
In PSM’s round-up this week: HHS defies 20 years of expertise and guidance and recent negative feedback to finalize regulations for state-based Canadian drug importation programs, forward movement on the Safe Therapeutics Act, and more #covidscam and counterfeit drug news.
[...]